A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine

Development of optimal SARS-CoV-2 vaccines to induce potent, long-lasting immunity and provide cross-reactive protection against emerging variants remains a high priority. Here, we report that a modified porous silicon microparticle (mPSM) adjuvant to SARS-CoV-2 receptor-binding domain (RBD) vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam, Awadalkareem, Shi, Qing, Wang, Binbin, Zou, Jing, Mai, Junhua, Osman, Samantha R., Wu, Wenzhe, Xie, Xuping, Aguilar, Patricia V, Bao, Xiaoyong, Shi, Pei-Yong, Shen, Haifa, Wang, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173827/
https://www.ncbi.nlm.nih.gov/pubmed/35688318
http://dx.doi.org/10.1016/j.trsl.2022.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173827/
https://www.ncbi.nlm.nih.gov/pubmed/35688318
http://dx.doi.org/10.1016/j.trsl.2022.06.004

Ejemplares similares